These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8665561)

  • 1. Transient elevations in pancreatic enzymes in response to a cholinesterase inhibitor.
    Pomara N; Citrome L
    Clin Neuropharmacol; 1995 Oct; 18(5):464-5. PubMed ID: 8665561
    [No Abstract]   [Full Text] [Related]  

  • 2. Side effects of long acting cholinesterase inhibitors.
    Beermann B
    Acta Neurol Scand Suppl; 1993; 149():53-4. PubMed ID: 8128840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No association between tacrine transaminitis and the glutathione transferase theta genotype in patients with Alzheimer's disease.
    De Sousa M; Pirmohamed M; Kitteringham NR; Woolf T; Park BK
    Pharmacogenetics; 1998 Aug; 8(4):353-5. PubMed ID: 9731722
    [No Abstract]   [Full Text] [Related]  

  • 4. Tacrine-propargylamine derivatives with improved acetylcholinesterase inhibitory activity and lower hepatotoxicity as a potential lead compound for the treatment of Alzheimer's disease.
    Mao F; Li J; Wei H; Huang L; Li X
    J Enzyme Inhib Med Chem; 2015 Dec; 30(6):995-1001. PubMed ID: 25792506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Detection of the cholinesterase inhibitor tacrine and its main metabolites].
    Schütz H; Ahrens B; Erdmann F; Weiler G
    Arch Kriminol; 2001; 207(5-6):154-61. PubMed ID: 11508052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myoclonus induced by tacrine.
    Abilleira S; Viguera ML; Miquel F
    J Neurol Neurosurg Psychiatry; 1998 Feb; 64(2):281. PubMed ID: 9489553
    [No Abstract]   [Full Text] [Related]  

  • 7. [Should Alzheimer disease be treated with tacrine? Review of the literature].
    Arsland D; Laake K
    Tidsskr Nor Laegeforen; 1996 Sep; 116(23):2791-4. PubMed ID: 8928167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancing the tolerability of tacrine with propantheline.
    Faber RA; Negro PJ
    Am J Psychiatry; 1999 Jan; 156(1):156. PubMed ID: 9892315
    [No Abstract]   [Full Text] [Related]  

  • 9. Cholinergic delirium and neurotoxicity associated with tacrine for Alzheimer's dementia.
    Trzepacz PT; Ho V; Mallavarapu H
    Psychosomatics; 1996; 37(3):299-301. PubMed ID: 8849507
    [No Abstract]   [Full Text] [Related]  

  • 10. Tolerance to tacrine, arterial hypotension and leuko-araiosis in Alzheimer's disease.
    Lebert F; Mouly C; Pasquier F
    Age Ageing; 1998 Sep; 27(5):654. PubMed ID: 12675108
    [No Abstract]   [Full Text] [Related]  

  • 11. [Convulsive crisis as a possible adverse reaction to the treatment with tacrine in Alzheimer's disease].
    García-Díaz JD; Fraguas C; Garcimartín C
    Med Clin (Barc); 1998 Sep; 111(7):279. PubMed ID: 9789247
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacoepidemiology of tacrine in Alzheimer's disease.
    Begaud B; Haramburu F; Miremont G
    Methods Find Exp Clin Pharmacol; 1996; 18 Suppl B():77-8. PubMed ID: 8899701
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical study of patients with Alzheimer's disease under treatment with tacrine].
    García-López MT; Guardado-Santervás P
    Rev Neurol; 2001 Feb 16-28; 32(4):394-7. PubMed ID: 11398762
    [No Abstract]   [Full Text] [Related]  

  • 14. Alzheimer's disease: the role of tacrine therapy.
    Jogerst G
    Iowa Med; 1995 Oct; 85(10):409-11. PubMed ID: 7591656
    [No Abstract]   [Full Text] [Related]  

  • 15. Cholinesterase inhibitors in the treatment of Alzheimer's disease: a comparison of tolerability and pharmacology.
    Nordberg A; Svensson AL
    Drug Saf; 1998 Dec; 19(6):465-80. PubMed ID: 9880090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical trials with velnacrine: (PROPP) the physician reference of predicted probabilities--a statistical model for the estimation of hepatotoxicity risk with velnacrine maleate.
    Hardiman S; Miller K; Murphy M
    Acta Neurol Scand Suppl; 1993; 149():46-52. PubMed ID: 8128839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tacrine against Alzheimer disease? Still uncertain for which patients may the treatment be beneficial].
    Wallin A
    Lakartidningen; 1996 Jan; 93(1-2):22-4. PubMed ID: 8544526
    [No Abstract]   [Full Text] [Related]  

  • 18. Tacrine and its analogues impair mitochondrial function and bioenergetics: a lipidomic analysis in rat brain.
    Melo T; Videira RA; André S; Maciel E; Francisco CS; Oliveira-Campos AM; Rodrigues LM; Domingues MR; Peixoto F; Manuel Oliveira M
    J Neurochem; 2012 Mar; 120(6):998-1013. PubMed ID: 22192081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer's disease.
    Hier DB
    Surg Neurol; 1997 Jan; 47(1):84-5. PubMed ID: 8986173
    [No Abstract]   [Full Text] [Related]  

  • 20. First experience with the application of 7-methoxytacrine to psychiatric patients.
    Zapletálek M; Hanus H; Fusek J; Hrdina V
    Act Nerv Super (Praha); 1989 Dec; 31(4):305-6. PubMed ID: 2576923
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.